Evidence map›Paper›PMID 42170356›Full record

ReviewArrhythmia & electrophysiology review2026

Ablation Methods and Catheter Settings for Ventricular Tachycardia Ablation: A Bench to Bedside Review: Part 1.

Maria Niespialowska-Steuden, John Silberbauer, Jaffar Al-Sheikhli, Rafaella Siang, Joseph Mayer, Tarvinder Dhanjal

Abstract readReview
In one paragraph

Review in Arrhythmia & electrophysiology review, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Maria Niespialowska-SteudenDepartment of Cardiology, University Hospital Southampton NHS Trust Southampton, UK.ORCID https://orcid.org/0000-0002-1839-9465
John SilberbauerDepartment of Cardiology, Royal Sussex County Hospital Brighton, UK.ORCID https://orcid.org/0000-0002-2245-7285
Jaffar Al-SheikhliDepartment of Cardiology, University Hospital of Coventry and Warwickshire NHS Trust Coventry, UK.ORCID https://orcid.org/0009-0009-6916-5472
Rafaella SiangDepartment of Cardiology, University Hospital of Coventry and Warwickshire NHS Trust Coventry, UK.ORCID https://orcid.org/0000-0001-6750-8544
Joseph MayerDepartment of Cardiology, University Hospital of Coventry and Warwickshire NHS Trust Coventry, UK.ORCID https://orcid.org/0000-0002-8882-7357
Tarvinder DhanjalDepartment of Cardiology, University Hospital of Coventry and Warwickshire NHS Trust Coventry, UK.ORCID https://orcid.org/0000-0001-5806-8567

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Catheter ablation is the primary treatment for ventricular tachycardia (VT) in patients with structural heart disease. Unfortunately, its long-term success remains limited. Although mapping techniques have advanced considerably, optimal ablation indices remain essential but less well defined. This two-part comprehensive review bridges the gap between bench and bedside by evaluating methods, technologies, and VT-specific lesion parameters. Here, in part 1, we critically examined conventional and emerging techniques, including radiofrequency (RF), high-power short-duration ablation, temperature-controlled RF. In the accompanying paper, part 2, we focus on bipolar RF ablation, pulsed field ablation and ultra-low-temperature cryoablation, venous ethanol and needle ablation. Despite the growing set of tools available for VT operators, clinical data on the practical and safe creation of lesions remain scarce. The evidence supporting most of the techniques reviewed is limited. We emphasise the need for personalised ablation strategies based on substrate and myocardial anatomy and advocate for the development of future integrated, metric-driven technologies.

Indexed as

ablation metricscatheter ablationradiofrequency energystructural heart diseaseVentricular tachycardia

Identifiers

PMID42170356
PMCPMC13187937

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.